Biomaterials - Bone substitutes - Spine fusion
SMART BIOMATERIALS
Graftys is a Young Innovative Company specializing in bone tissue engineering. Graftys has strong expertise in biomaterials synthesis and works in several original directions with a view to have eventually one of the widest product offers on the market.
Our Research & Development activities range from latest generation synthetic bone substitutes to biological repair of cartilage and intervertebral discs, via resorbable bioactive cements and intelligent biomaterials (biomatériaux intelligents®).
Certified ISO 9001:2000 and ISO 13485:2003 , Graftys is committed to ensure
the excellence of its products and services, thus guaranteeing total client
satisfaction.
08/31/03 - FDA Approval for Graftys® BCP
Graftys® BCP, synthetic bone void filler, has been FDA approved for its indications in orthopaedics. The Graftys® BCP has had EC accreditation since January 2007.
>> More Informations...
08/04/02 - GRIBOI 2008 : Oral and poster sessions presented by GRAFTYS
Oral and poster sessions presented by the GRAFTYS collaborators at the 18th GRIBOI Conference (5th and 6th May in Montreal).
>> More Informations...
08/29/07 - Graftys consolidates its range with Graftys® BCP Dental
As part of the development of our dental activity, we are currently looking for French and international distributors for Graftys® BCP Dental.
>> More Informations...
Biomaterials - Bone substitutes - Spine fusion
GRAFTYS - Eiffel Park - Bâtiment D - 415, rue Claude Nicolas Ledoux
Pôle d'Activités d'Aix en Provence - 13 854 AIX EN PROVENCE Cedex 3
Tel : + 33 (0)4 42 60 30 00 - Fax : + 33 (0)4 42 60 30 11